Join
Live feed
·
PRReleasevia Quantisnow
Biotricity Inc. logo

Biotricity Files FDA 510(k) for a new Form Factor of its Biotres Cardiac Monitoring Device to Expand its Revenue Growth

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BTCY (Biotricity Inc.) and more on Quantisnow.